Search Results - "Tofilon, Peter"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    AT-33A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME

    AT-33A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME by Krauze, Andra V., Myrehaug, Sten D., Chang, Michael G., Holdford, Diane J., Smith, Sharon, Shih, Joanna, Tofilon, Peter, Fine, Howard, Camphausen, Kevin A.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…BACKGROUND: Glioblastoma (GBM) remains an aggressive brain tumor with poor prognosis. Valproic acid (VPA) is an antiepileptic agent that has been shown to have…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    AT-33 A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME

    AT-33 A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME by Krauze, Andra V, Myrehaug, Sten D, Chang, Michael G, Holdford, Diane J, Smith, Sharon, Shih, Joanna, Tofilon, Peter, Fine, Howard, Camphausen, Kevin A

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…BACKGROUND: Glioblastoma (GBM) remains an aggressive brain tumor with poor prognosis. Valproic acid (VPA) is an antiepileptic agent that has been shown to have…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: